| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
9,023 | 8,182 | 5,015 | 22,006 | 2,944 |
| Cost of Revenue
|
-10,685 | -11,047 | -8,528 | -25,361 | -2,927 |
|
Gross Profit
|
-1,662 | -2,865 | -3,513 | -3,355 | 17 |
| Selling, General and Administrative Expenses
|
-21,298 | -20,307 | -17,749 | -18,110 | -16,300 |
|
Research and Development Expenses
|
-1,761 | -1,783 | -2,421 | -1,868 | -2,184 |
| Depreciation, Amortization and Depletion
|
-1,278 | -1,220 | -1,314 | -1,056 | -1,150 |
| Provision Expense/Write-Back
|
-- | -- | -- | 0 | -554 |
| Other Income/Expense, Operating
|
931 | 2,038 | 1,150 | 1,960 | 1,239 |
|
Operating Income/Expenses
|
-23,406 | -21,272 | -20,334 | -19,074 | -18,949 |
|
Total Operating Profit/Loss
|
-25,068 | -24,137 | -23,847 | -22,429 | -18,932 |
| Total Net Finance Income/Expense
|
523 | 696 | 1,252 | -514 | -3 |
| Net Investment Income
|
-268 | -172 | 8 | 113 | 448 |
|
Rental Income
|
0 | 27 | 18 | 0 | -- |
| Irregular Income/Expenses
|
-740 | -508 | -228 | -349 | -50 |
|
Non-Operating Income/Expenses, Total
|
-485 | 43 | 1,050 | -750 | 395 |
|
Pretax Income
|
-25,553 | -24,094 | -22,797 | -23,179 | -18,537 |
| Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-25,553 | -24,094 | -22,797 | -23,179 | -18,537 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-25,553 | -24,094 | -22,797 | -23,179 | -18,537 |
|
Net Income after Non-Controlling/Minority Interests
|
-25,553 | -24,094 | -22,797 | -23,179 | -18,537 |
|
Net Income Available to Common Stockholders
|
-25,553 | -24,094 | -22,797 | -23,179 | -18,537 |
|
Diluted Net Income Available to Common Stockholders
|
-25,553 | -24,094 | -22,797 | -23,179 | -18,537 |
| Basic EPS
|
-0.05 | -0.05 | -0.07 | -0.13 | -0.16 |
| Diluted EPS
|
-0.05 | -0.05 | -0.07 | -0.13 | -0.16 |
|
Basic Weighted Average Shares Outstanding
|
536,979.18 | 472,876.61 | 342,812.36 | 178,137.03 | 118,798.09 |
|
Diluted Weighted Average Shares Outstanding
|
549,326.86 | 482,722.67 | 344,057.64 | 179,628.01 | 120,438.22 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-25,941 | -24,655 | -23,914 | -22,530 | -18,534 |
|
EBITDA
|
-24,469 | -23,293 | -22,531 | -21,131 | -17,184 |
|
Normalized EBITDA
|
-22,176 | -20,600 | -18,000 | -22,400 | -16,844 |
12/31/2022 - 4/25/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade